Board reviewing major capital investment and capital allocation decision

Five Questions Boards Should Ask Before Approving Major Capital

Executive Summary

Major capital decisions are among the most consequential decisions a board makes.

A new manufacturing plant. A large technology transformation. An acquisition. A new market entry. A major capacity expansion. A significant investment in infrastructure or digital capability.

The business case will usually include a familiar set of numbers: investment required, projected revenue, margins, IRR, payback period, and ROI.

Those numbers matter.

But a board should not confuse a financially attractive business case with a good capital-allocation decision.

Before approving significant capital, the board should ask five broader questions:

  1. Is this investment strategically aligned with where the company wants to go?
  2. What assumptions and risks sit behind the projected returns?
  3. Is this the best use of the capital available?
  4. Does the organisation have the capability and capacity to execute?
  5. How will we know early if the investment is not delivering as expected?

The board does not need to manage the project. It needs to ensure that the decision-making process is rigorous enough to protect long-term enterprise value.

Capital Allocation Is About Choices

I have spent much of my career looking at businesses from different perspectives: finance, technology, transformation, operations and entrepreneurship.

One lesson has remained consistent:

Capital allocation is ultimately about choices.

There is always a constraint.

Capital is limited. Management bandwidth is limited. Talent is limited. Time is limited.

Approving one major investment inevitably means resources aren’t available for something else.

That is why the board’s question should go beyond:

“What return will we get?”

The more important question is:

“Why is this the right use of our resources, at this point in the company’s journey?”

Here are five questions that can materially improve that conversation.

1. Is the Investment Strategically Aligned?

The first question should not be about ROI.

It should be about strategic relevance.

A project can have an attractive projected return and still be inconsistent with the company’s long-term direction.

For example, a company may be trying to become asset-light while considering a large capacity investment. Or it may be shifting toward digital distribution while still allocating substantial capital to legacy infrastructure.

The numbers may work.

The strategy may not.

The board should ask:

  • Which strategic priority does this investment advance?
  • What capability will it create?
  • What happens if we do not make this investment?
  • Is this investment preparing the company for the future or simply reinforcing the past?
  • Would we make the same decision if we were starting with a clean sheet?

That last question can be particularly revealing.

Capital should not automatically follow historical allocation patterns simply because a business unit has received capital in the past.

Strategy should determine capital allocation, not history.

2. What Assumptions and Risks Sit Behind the Returns?

Every investment case is built on assumptions.

Revenue growth. Pricing. Market share. Costs. Utilisation. Interest rates. Currency. Customer adoption. Technology performance. Regulatory conditions.

The projected IRR or ROI is only as reliable as the assumptions underneath it.

Boards should therefore resist the temptation to debate only the headline return.

Instead, ask:

  • Which assumptions have the greatest impact on the outcome?
  • Which assumptions are most uncertain?
  • What does the downside scenario look like?
  • What happens if revenue is 20% lower than projected?
  • What happens if costs are higher or implementation takes longer?
  • Which risks can actually be mitigated?
  • What would cause us to reconsider the investment?

One useful discipline is to ask management to present the strongest argument against the investment, not just the case supporting it.

That changes the nature of the discussion.

The objective is not to create unnecessary scepticism. It is to reduce the possibility of groupthink and make uncertainty visible before capital is committed.

A board should be comfortable approving risk.

It should be less comfortable approving unexamined risk.

3. Is This the Best Use of the Capital Available?

This may be the most important question, and the one most often overlooked.

Imagine the company has ₹500 crore available for deployment and management proposes a ₹300 crore project with an expected 18% return.

The natural reaction may be:

“An 18% return looks attractive. Let’s approve it.”

But attractive compared with what?

Could the same capital:

  • strengthen the balance sheet?
  • reduce expensive debt?
  • fund another growth opportunity?
  • improve technology infrastructure?
  • acquire a strategic capability?
  • return capital to shareholders?
  • be retained for a future opportunity?

Capital allocation should therefore not be evaluated in isolation.

The question is not merely:

“Is this a good investment?”

It is:

“Is this a better use of capital than the realistic alternatives available to us?”

This is where the board’s enterprise perspective matters most.

Business-unit leaders naturally advocate for their own projects. That is part of their role.

The board’s role is different.

It must look across the enterprise and consider where the next rupee of capital can create sustainable value.

Capital should follow opportunity, not entitlement.

4. Does the Organisation Have the Capability to Execute?

A spreadsheet does not execute a strategy.

People do.

This sounds obvious, but major investments frequently underestimate the organisational capability required to deliver them.

A large technology programme may require skills the company does not currently possess.

An acquisition may require integration capabilities that management has limited experience with.

A manufacturing expansion may require new leadership, supply-chain capabilities and operational expertise.

A new market may demand a completely different distribution model.

The board should therefore ask:

  • Who will be accountable for delivering the investment?
  • Does management have the required capability?
  • Do we have the necessary talent?
  • How much management bandwidth will this consume?
  • What other initiatives will receive less attention?
  • What organisational changes are required?
  • Are we underestimating the complexity of execution?

There is an important distinction between having the financial capacity to fund an initiative and having the organisational capacity to execute it.

A company may have ₹1,000 crore available for investment but insufficient leadership bandwidth to execute five major transformations simultaneously.

That is still a capital-allocation constraint.

Capital without execution capacity is an assumption, not a strategy.

5. How Will We Know Early If We Are Wrong?

One of the weaknesses of traditional investment approval is that the decision can appear binary:

Approve → Fund → Execute → Review results later.

By the time disappointing results become obvious, significant capital may already have been committed.

A better approach is to build adaptability into the investment decision itself.

The board should ask:

  • What milestones should management achieve?
  • Which leading indicators will tell us whether the thesis is working?
  • When will the investment be reviewed?
  • What are the escalation triggers?
  • Under what circumstances should additional capital be released?
  • What evidence would make us slow down, modify or stop the investment?

This is particularly important for large, uncertain or multi-year investments.

Approval does not necessarily have to mean committing the entire capital upfront.

Capital can sometimes be staged against evidence.

That creates a valuable governance mechanism: management gets the resources needed to progress, while the board retains visibility and decision points as new information emerges.

The objective is not to eliminate failure.

That is impossible.

The objective is to ensure that when an investment begins to underperform, the organisation recognises it early enough to respond.

A Simple Board-Level Framework

Before approving a major capital investment, the board can use a simple five-part framework:

Dimension

Board Question

Strategy

Does this advance our strategic priorities?

Risk

What assumptions could prove wrong?

Alternatives

Is this the best use of available capital?

Execution

Do we have the capability and capacity to deliver?

Adaptability

What evidence would make us change course?

Notice what is missing from the framework:

ROI as the sole decision criterion.

ROI remains important.

But it is one input into a much larger governance conversation.

The Board Should Challenge the Decision. Not Run the Project

The other extreme is also dangerous.

Boards should not become operating committees that second-guess every management decision or attempt to manage projects themselves.

Management needs the authority to run the business.

The board’s responsibility is to ensure that significant capital decisions face an appropriate level of strategic challenge, risk oversight, and accountability.

The quality of governance is therefore not measured by how many projects the board rejects.

Nor by how quickly it approves them.

It is measured by whether the board creates an environment in which significant capital decisions are made with sufficient information, challenge and discipline.

Five Questions Worth Asking in the Boardroom

When a major capital proposal comes to the board, these five questions can change the conversation:

  1. Why does this investment matter to our strategy?
  2. Which assumptions must be true for the investment to deliver the expected returns?
  3. What is the strongest argument against approving it?
  4. What organisational capability and management bandwidth will it consume?
  5. What evidence would make us change our mind after approval?

These questions are simple.

The discussion they trigger may not be.

And that is precisely the point.

The Real Capital-Allocation Question

Boards are often presented with a business case and asked whether the numbers justify the investment.

But governance requires a broader perspective.

The board needs to understand whether the investment fits the strategy, whether the risks are understood, whether alternatives have been considered, whether the organisation can execute, and whether the company has mechanisms to adapt when reality differs from the original business case.

Ultimately, the board does not need to predict which investment will become the next big success.

It needs to ensure the company has a disciplined process for making those choices, and the willingness to reallocate resources when the evidence changes.

The real question is therefore not:

“Will this investment generate an attractive ROI?”

It is:

“Is this the right use of our scarce capital, given our strategy, risks, alternatives and ability to execute?”

That is where capital allocation moves from being a finance exercise to becoming a boardroom responsibility.

Board Takeaway

ROI tells you what an investment might return.

Good governance asks whether it is the right investment to make, and how the board will know if that decision needs to change.

 

Learn more about Rajesh’s Independent Director and board governance perspective.